[HTML][HTML] Review on recent progress of nanostructured anode materials for Li-ion batteries
This review highlights the recent research advances in active nanostructured anode materials
for the next generation of Li-ion batteries (LIBs). In fact, in order to address both energy …
for the next generation of Li-ion batteries (LIBs). In fact, in order to address both energy …
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Breast cancer is the most common type of malignancy diagnosed in women. In the metastatic
setting this disease is still uncurable. Taxanes represent an important class of antitumor …
setting this disease is still uncurable. Taxanes represent an important class of antitumor …
Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
… (E) Furthermore these particles must be taken up into the cells, usually bound to cellular
receptors and transported into the cytoplasm through a receptor mediated endocytosis process. (…
receptors and transported into the cytoplasm through a receptor mediated endocytosis process. (…
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
…, S Koletzko, P Lionetti, E Miele… - Journal of Crohn's …, 2014 - academic.oup.com
Children and adolescents with Crohn's disease (CD) present often with a more complicated
disease course compared to adult patients. In addition, the potential impact of CD on growth, …
disease course compared to adult patients. In addition, the potential impact of CD on growth, …
Effect of a probiotic preparation (VSL# 3) on induction and maintenance of remission in children with ulcerative colitis
E Miele, F Pascarella, E Giannetti… - Official journal of the …, 2009 - journals.lww.com
OBJECTIVES: Several probiotic compounds have shown promise in the therapy of ulcerative
colitis (UC). However, a strong sustained benefit remains to be seen. Uncontrolled pilot …
colitis (UC). However, a strong sustained benefit remains to be seen. Uncontrolled pilot …
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
… (E) Western blot analysis of endogenous Gli1 protein levels in Daoy cells overexpressing
miR‐324‐5p or miRNA mimic negative control (ctr). All data in (B–D) are average values±sd …
miR‐324‐5p or miRNA mimic negative control (ctr). All data in (B–D) are average values±sd …
Histone deacetylase and Cullin3–RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
…, L Pietrosanti, E De Smaele, E Ferretti, E Miele… - Nature cell …, 2010 - nature.com
… (e) REN does not inhibit the Gli1 K518R mutant. HEK293T cells were transfected with the
indicated … Results in a–c and e are shown as the mean ± sd (n = 3). Ctr, control. For uncropped …
indicated … Results in a–c and e are shown as the mean ± sd (n = 3). Ctr, control. For uncropped …
Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
…, M Zuckermann, O Witt, T Bloom, C Mitchell, E Miele… - Cancer discovery, 2020 - AACR
Infant high-grade gliomas in the cerebral hemispheres comprise novel subgroups, with a
prevalence of ALK, NTRK1/2/3, ROS1 , or MET gene fusions. Kinase fusion–positive tumors …
prevalence of ALK, NTRK1/2/3, ROS1 , or MET gene fusions. Kinase fusion–positive tumors …
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases
…, DS Monos, C Strisciuglio, A Staiano, E Miele… - Nature medicine, 2015 - nature.com
Genome-wide association studies (GWASs) have identified hundreds of susceptibility genes,
including shared associations across clinically distinct autoimmune diseases. We …
including shared associations across clinically distinct autoimmune diseases. We …
Gastrointestinal manifestations in children with cerebral palsy
…, G Capano, A Romano, L Florimonte, E Miele… - Brain and …, 1999 - Elsevier
We describe the prevalence and nature of gastrointestinal (GI) symptoms in 58 children
affected by cerebral palsy (range: from 6 months to 12 years of age) referred to a pediatric …
affected by cerebral palsy (range: from 6 months to 12 years of age) referred to a pediatric …